{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-178757","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.729325+00:00","generated_at":"2026-06-24T23:56:40.065634+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Agios shareholders elect directors, approve say-on-pay, ratify PwC at 2022 annual meeting","bullets":["Elected Jacqualyn A. Fouse, David Scadden, David P. Schenkein as class III directors (48.5M, 48.5M, 45.4M votes for).","Advisory vote on executive compensation approved: 45.0M for, 4.5M against, 9K abstain.","Shareholders recommended say-on-pay every 1 year (48.7M votes); Board adopts annual frequency.","Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022: 50.6M for, 140K against.","Broker non-votes of 1.17M on director elections and advisory items."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-178757","json":"https://secwatch.observer/filing/0001193125-22-178757.json","markdown":"https://secwatch.observer/filing/0001193125-22-178757.md","text":"https://secwatch.observer/filing/0001193125-22-178757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/0001193125-22-178757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/d342593d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:56:40.065634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}